Stockscreener 앱 받기
10.76
0.09%
0.010
전일 마감가:
$10.75
열려 있는:
$10.76
하루 거래량:
29,709
Relative Volume:
0.81
시가총액:
$261.22M
수익:
-
순이익/손실:
$6.66M
주가수익비율:
54.29
EPS:
0.1982
순현금흐름:
$-379.20K
1주 성능:
+0.09%
1개월 성능:
+0.47%
6개월 성능:
+2.77%
1년 성능:
+4.87%
1일 변동 폭
$10.75
$10.77
1주일 범위
$10.74
$10.77
52주 변동 폭
$10.23
$10.77
Drugs Made In America Acquisition Corp Stock (DMAA) Company Profile
명칭
Drugs Made In America Acquisition Corp
전화
646-726-7074
주소
420 LEXINGTON AVENUE, NEW YORK
Compare DMAA vs XXI, LION, UMAC, AAC, CCXI
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DMAA
Drugs Made In America Acquisition Corp
|
10.76 | 260.37M | 0 | 6.66M | -379.20K | 0.1982 |
XXI
Twenty One Capital Inc
|
6.10 | 3.48B | 0 | 4.35M | 456.40K | 0.3397 |
LION
Lionsgate Studios Corp
|
11.17 | 3.41B | 2.63B | -175.60M | 11.40M | -0.7173 |
UMAC
Unusual Machines Inc
|
23.76 | 1.30B | 17.25M | -5.64M | -40.16M | -0.3337 |
AAC
Ares Acquisition Corporation
|
10.06 | 761.82M | 0 | -10.01M | -1.23M | -0.08 |
CCXI
Churchill Capital Corp Xi
|
13.40 | 783.70M | 0 | 0 | 0 | 0.0647 |
Drugs Made In America Acquisition Corp 주식(DMAA)의 최신 뉴스
Drugs Made In America Acquisition II (DMII) Holds at $10.15 as SPAC Shares Trade Flat Within RangeValue Area Low - dars.gov.et
Pfizer Inc. - Britannica
Drugs Made In America Acquisition (NASDAQ:DMAA) Shares Down 0%Should You Sell? - MarketBeat
Drugs (DMII): Closes 0.20% Higher at $10.14 in Latest Trading; Chart Watch: $9.63 and $10.65 Define the Nearby Reference Levels in Latest TradingBuy Signal Reports - vinanet.vn
Drugs Made In America Acquisition Corp. (DMAA) Stock Price, Chart, News & Analysis - Securities.io
Drugs Made In America Acquisition II (DMII) Earnings Date and Reports 2026 - MarketBeat
DMII Holds Steady at $10.13 as Acquisition Vehicle Trades in Tight RangeGamma Exposure - vinanet.vn
Drugs Made In America Acquisition Corp. (DMAA) logs $3.7M income as redemptions cut SPAC trust - Stock Titan
Drugs Made In America II (DMII) earns $8.7M but warns on going concern - Stock Titan
Drugs Made In America Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Karpus Management (DMAA) discloses 10.33% beneficial stake in SPAC - Stock Titan
Drugs Made In America (DMAA): First Trust funds disclose 3.24% beneficial stake - Stock Titan
DMAA Holds at $10.69 as SPAC Awaits Definitive Acquisition TargetPCR Moving Average - vinanet.vn
Drugs Made In America Acquisition II Corp. (DMIIU) Holds Steady at $10.17 as SPAC Unit Trades in Tight RangeIchimoku Cloud - vinanet.vn
Glazer Capital (DMAA) discloses 4.12% beneficial stake in Drugs Made in America - Stock Titan
Mizuho Financial Group (DMAA) discloses 8.5% beneficial stake in SPAC - Stock Titan
DMAAR Rights Hold Flat at $0.15 as Range-Bound Trading PersistsDouble Top - Vinanet
Drugs Made In America Acquisition Corp (DMAA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
DMII Holds at $10.11: Drugs Made In America Acquisition II Shows Typical Pre-Deal StabilitySystematic Flow - Vinanet
Drugs Made In America Acquisition Corp (DMAA) Stock News Today - TradingKey
Drugs Made In America Acquisition Corp. Revenue Breakdown – BOATS:DMAAU - TradingView
Drugs Made In America Acquisition Corp. Revenue Breakdown – BOATS:DMAAR - TradingView
AstraZeneca falls to third-largest UK company amid US merger talks - The Guardian
DMAAR Rights Edge Up to $0.16 as Tight Range Between Support and Resistance PersistsVolume Oscillator - Vinanet
Drugs Made In America Acquisition Corp. Revenue Breakdown – NASDAQ:DMAAU - TradingView
DMII Holds Steady at $10.12 as SPAC Trades Near Trust ValueDealer Positioning - Vinanet
DMAA Holds Steady at $10.71 as SPAC Continues Trading in Tight RangeSynthetic Short - vinanet.vn
Law firm launches legal inquiries into mergers of LXP, DMAA, PSNL, and FNWD for shareholder protection. - Pluang
DMII|Drugs Made In America Acquisition II Ord Shs|Price:10.105|Chg%:+0.005 - TradingKey
DMAA|Drugs Made In America Acquisition Corp|Price:10.709|Chg%:+0.009 - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Cash Flow - TradingKey
Drugs Made In America Acquisition II Corp. Revenue Breakdown – NASDAQ:DMIIR - TradingView
Drugs Made In America Acquisition Corp (DMAA) Institutional Confidence - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition Corp - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Institutional Confidence - TradingKey
Drugs Made In America Acquisition II Ord Shs - TradingKey
162,795 Shares in Drugs Made In America Acquisition Corp. $DMAA Purchased by Sona Asset Management US LLC - MarketBeat
DMII|Drugs Made In America Acquisition II Ord Shs|Price:10.140|Chg%:+0.020 - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Price to book forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAAR - TradingView
Drugs Made In America Acquisition II Ord Shs (DMII) Balance Sheet - tradingkey.com
Drugs Made In America Acquisition Corp (DMAA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Drugs Made In America Acquisition II Corp. Right (DMIIR) Rights See Modest Gain Amid Tight Trading RangeBPI Bear Confirmed - dars.gov.et
BLZR|Trailblazer Acquisition Corp|Price:10.160| - TradingKey
Drugs Made In America Acquisition II Corp. Revenue Breakdown – NASDAQ:DMII - TradingView
TradingKey - TradingKey
LATA|Galata Acquisition Corp II|Price:10.150|Chg%:+0.020 - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Balance Sheet - TradingKey
Drugs Made In America Acquisition Corp (DMAA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.10%
0.70%
자본화:
|
볼륨(24시간):